GRP
BMRN icon

Global Retirement Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Global Retirement Partners’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$219K Buy
3,691
+2,440
+195% +$133K ﹤0.01% 1411
2025
Q3 		$67.8K Sell
1,251
-1,274
-50% -$72.9K ﹤0.01% 1729
2025
Q2 		$139K Buy
+2,525
New +$149K ﹤0.01% 1271
2024
Q4 		$178K Buy
2,708
+422
+18% +$28.3K 0.01% 1013
2024
Q3 		$161K Buy
2,286
+4
+0.2% +$334 ﹤0.01% 1007
2024
Q2 		$188K Buy
2,282
+10
+0.4% +$833 0.01% 910
2024
Q1 		$198K Buy
2,272
+40
+2% +$3.58K 0.01% 793
2023
Q4 		$209K Sell
2,232
-37
-2% -$3.27K 0.01% 748
2023
Q3 		$195K Buy
2,269
+14
+0.6% +$1.25K 0.01% 675
2023
Q2 		$195K Buy
2,255
+148
+7% +$13.9K 0.01% 707
2023
Q1 		$197K Buy
2,107
+7
+0.3% +$726 0.01% 672
2022
Q4 		$217K Sell
2,100
-50
-2% -$4.69K 0.01% 572
2022
Q3 		$186K Hold
2,150
– – 0.01% 581
2022
Q2 		$178K Buy
2,150
+50
+2% +$3.98K 0.01% 579
2022
Q1 		$165K Buy
+2,100
New +$176K 0.01% 601
2021
Q4 		– Sell
-2,020
Closed -$156K – 413
2021
Q3 		$156K Hold
2,020
– – 0.02% 529
2021
Q2 		$169K Sell
2,020
-10
-0.5% -$793 0.02% 499
2021
Q1 		$153K Buy
2,030
+7
+0.3% +$572 0.02% 465
2020
Q4 		$177K Buy
2,023
+100
+5% +$7.93K 0.02% 420
2020
Q3 		$146K Sell
1,923
-100
-5% -$10.1K 0.02% 412
2020
Q2 		$250K Buy
2,023
+16
+0.8% +$1.59K 0.04% 316
2020
Q1 		$170K Buy
2,007
+7
+0.4% +$603 0.03% 345
2019
Q4 		$169K Hold
2,000
– – 0.03% 396
2019
Q3 		$135K Hold
2,000
– – 0.02% 428
2019
Q2 		$171K Buy
2,000
+1,900
+1,900% +$163K 0.03% 363
2019
Q1 		$9K Buy
+100
New +$9.27K ﹤0.01% 1071

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Global Retirement Partners's BMRN Position: Q4 2025 in Review

Global Retirement Partners increased its BioMarin Pharmaceuticals (BMRN) stake by 195% in Q4 2025, buying an estimated $133K and bringing the position to 3,691 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #1411.

Global Retirement Partners first reported a position in BMRN in Q1 2019 and has held it in 26 quarters since. The position peaked at $250K in Q2 2020. 538 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.

  • Global Retirement Partners held 3,691 shares of BioMarin Pharmaceuticals worth $219K as of Q4 2025.
  • Global Retirement Partners bought 2,440 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $133K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #1411 holding.
  • Global Retirement Partners first reported a position in BioMarin Pharmaceuticals in Q1 2019 and has held it in 26 quarters since.
  • Global Retirement Partners's BioMarin Pharmaceuticals position peaked at $250K in Q2 2020.
  • 538 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.